InvestSMART

Argent Biopharma Limited (ASX: RGT) - Announcements

- Current share price for RGT : $0.072

ASX company news and announcements for Argent Biopharma Limited (RGT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Argent Biopharma Limited (RGT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Argent Biopharma Limited (RGT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Argent Biopharma Limited (RGT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8 Refinancing of Convertible Security Agreement 23 Apr 2025 12:56PM $0.180 $0.072 fallen by 60%
$8 Operational and Clinical Development Update 17 Apr 2025 8:23AM $0.175 $0.072 fallen by 58.86%
$8 Strategic Agreement to Enhance Cannabinoid Development 15 Apr 2025 9:08AM $0.180 $0.072 fallen by 60%
$8 Results of Meeting 11 Apr 2025 6:25PM $0.180 $0.072 fallen by 60%
$8 Strategic Collaboration Agreement for Malta Facility 9 Apr 2025 9:09AM $0.180 $0.072 fallen by 60%
$8 CannEpil Receives Approval for Prescription in Germany 3 Apr 2025 8:49AM $0.130 $0.072 fallen by 44.62%
$8 CimetrA Phase IIb Clinical Trial Results 17 Mar 2025 8:21AM $0.130 $0.072 fallen by 44.62%
$8 Exclusive Agreement for Malta Manufacturing Facility 12 Mar 2025 9:48AM $0.125 $0.072 fallen by 42.40%
$8 Notice of General Meeting/Proxy Form 10 Mar 2025 3:22PM $0.160 $0.072 fallen by 55%
$8 Strategic Manufacturing Partnership with ECCPharm Limited 5 Mar 2025 9:54AM $0.145 $0.072 fallen by 50.34%
$8 Final Director's Interest Notice 5 Mar 2025 8:50AM $0.145 $0.072 fallen by 50.34%
$8 Initial Director's Interest Notice 5 Mar 2025 8:48AM $0.145 $0.072 fallen by 50.34%
$8 Appointment of Non-Executive Director 5 Mar 2025 8:45AM $0.145 $0.072 fallen by 50.34%
$8 Half Year Accounts 28 Feb 2025 4:15PM $0.125 $0.072 fallen by 42.40%
$8 Update on SINTEF Collaboration 13 Feb 2025 9:11AM $0.125 $0.072 fallen by 42.40%
$8 Corporate Update - Board Change 5 Feb 2025 9:31AM $0.140 $0.072 fallen by 48.57%
$8 Notification of cessation of securities - RGT 3 Feb 2025 7:36PM $0.130 $0.072 fallen by 44.62%
$8 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2025 6:50PM $0.140 $0.072 fallen by 48.57%
$8 s708A Cleansing Notice 16 Jan 2025 7:17PM $0.215 $0.072 fallen by 66.51%
$8 Notification regarding unquoted securities - RGT 16 Jan 2025 7:10PM $0.215 $0.072 fallen by 66.51%
$8 Application for quotation of securities - RGT 16 Jan 2025 6:57PM $0.215 $0.072 fallen by 66.51%
$8 Proposed issue of securities - RGT 7 Jan 2025 10:02AM $0.170 $0.072 fallen by 57.65%
$8 Proposed issue of securities - RGT 7 Jan 2025 10:01AM $0.170 $0.072 fallen by 57.65%
$8 Placing to Raise US$4,500,000 7 Jan 2025 10:01AM $0.170 $0.072 fallen by 57.65%
$8 Trading Halt 3 Jan 2025 9:34AM $0.170 $0.072 fallen by 57.65%

76 - 100 of 157 results

Page 4 of 7

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.